SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-18-022839
Filing Date
2018-04-27
Accepted
2018-04-27 06:20:10
Documents
4
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A tv492233_defa14a.htm DEFA14A 12895
2 GRAPHIC image_001.jpg GRAPHIC 91561
3 GRAPHIC image_002.jpg GRAPHIC 109544
4 GRAPHIC image_003.jpg GRAPHIC 54850
  Complete submission text file 0001144204-18-022839.txt   367081
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36860 | Film No.: 18780902
SIC: 2836 Biological Products, (No Diagnostic Substances)